List of Disclosures Posters Abdel, Matthew P., MD: American Association of Hip and Knee Surgeons: Board or committee member; Eur
Biosplice Therapeutics Closes $120 Million in Equity Financing to Advance Its Alternative Splicing Platform
![Safety, tolerability, and pharmacokinetics of Aurora kinase B inhibitor AZD2811: a phase 1 dose-finding study in patients with advanced solid tumours | British Journal of Cancer Safety, tolerability, and pharmacokinetics of Aurora kinase B inhibitor AZD2811: a phase 1 dose-finding study in patients with advanced solid tumours | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-023-02185-2/MediaObjects/41416_2023_2185_Fig1_HTML.png)
Safety, tolerability, and pharmacokinetics of Aurora kinase B inhibitor AZD2811: a phase 1 dose-finding study in patients with advanced solid tumours | British Journal of Cancer
![In conversation with Samumed CEO Osman Kibar: Drugging Wnt, restoring youth and unconventional capital | Fierce Biotech In conversation with Samumed CEO Osman Kibar: Drugging Wnt, restoring youth and unconventional capital | Fierce Biotech](https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1565875982/Osman%20Kibar_CEO_800px.png?VersionId=7goxeQBGKDCsrvCjkpjaEQNynYYwnvR5)
In conversation with Samumed CEO Osman Kibar: Drugging Wnt, restoring youth and unconventional capital | Fierce Biotech
![After reaching a high with $12B valuation, Biosplice lays off staff and axes baldness program | Fierce Biotech After reaching a high with $12B valuation, Biosplice lays off staff and axes baldness program | Fierce Biotech](https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1644325553/Walking%20out.jpg/Walking%20out.jpg?VersionId=iyR7wzKsAh2GuOV348gRM5Mv4m6eAYA3)
After reaching a high with $12B valuation, Biosplice lays off staff and axes baldness program | Fierce Biotech
![PDF) Disruptive Innovations, Fundamental Strength and Stock Winners: Implications for Stock Index Revisions PDF) Disruptive Innovations, Fundamental Strength and Stock Winners: Implications for Stock Index Revisions](https://i1.rgstatic.net/publication/342175664_Disruptive_Innovations_Fundamental_Strength_and_Stock_Winners_Implications_for_Stock_Index_Revisions/links/633fc0d4ff870c55ce086bfc/largepreview.png)